BMC Cancer
(Aug 2020)
Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
- Congxiao Wang,
- Shifeng Liu,
- Lijing Peng,
- Kaixian Zhang,
- Wei Li,
- Hao Zhang,
- Ying Luan,
- Peishun Li,
- Xiaokun Hu
Affiliations
- Congxiao Wang
- Department of the Interventional Medical Center, the Affiliated Hospital of Qingdao University
- Shifeng Liu
- Department of the Interventional Medical Center, the Affiliated Hospital of Qingdao University
- Lijing Peng
- Department of Clinical Laboratory, the Affiliated Hospital of Qingdao University
- Kaixian Zhang
- Department of Oncology, Tengzhou Central People’s Hospital
- Wei Li
- Department of the Interventional Medical Center, the Affiliated Hospital of Qingdao University
- Hao Zhang
- Department of the Interventional Medical Center, the Affiliated Hospital of Qingdao University
- Ying Luan
- Department of Radiology, Zhongda Hospital, Medical School of Southeast University, Jiangsu Key Laboratory of Molecular and Functional Imaging
- Peishun Li
- Department of Oncology, Tengzhou Central People’s Hospital
- Xiaokun Hu
- Department of the Interventional Medical Center, the Affiliated Hospital of Qingdao University
- DOI
-
https://doi.org/10.1186/s12885-020-07246-w
- Journal volume & issue
-
Vol. 20,
no. 1
pp.
1
– 2
Abstract
Read online
An amendment to this paper has been published and can be accessed via the original article.
WeChat QR code
